GleamWall
中文EN

LUNG Pulmonx Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1127537 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.2%
TTM net income YoY25.0%
TTM EPS YoY28.4%
Revenue 3-yr CAGR11.1%
Net income 3-yr CAGR—

Margins

Gross margin77.4%
Operating margin-44.4%
Net margin-47.9%
FCF margin-28.8%
EBITDA margin-43.4%

Returns

ROE-90.3%
ROA-34.2%
ROIC (approx.)-155.9%
Asset turnover0.71x

Leverage & solvency

Liabilities / assets69.0%
Debt / equity1.11x
Current ratio4.05x
Interest coverage-9.39x

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-13.7%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$22.84M$22.76M$20.59M$22.60M$21.50M$23.86M$22.54M$23.77M
Cost of revenue$5.44M$5.01M$4.54M$5.06M$5.45M$6.66M$6.20M$6.17M
Gross profit$17.40M$17.74M$16.04M$17.54M$16.05M$17.20M$16.34M$17.59M
R&D expense$4.86M$5.03M$4.90M$4.58M$4.85M$5.31M$4.76M$4.00M
SG&A expense$20.02M$21.77M$24.10M$22.86M$25.60M$26.70M$26.15M$27.01M
Operating income-$7.49M-$9.06M-$12.96M-$9.90M-$14.39M-$14.80M-$14.56M-$13.42M
Interest expense$1.23M$1.22M$976,000$770,000$805,000$799,000$781,000$842,000
Pretax income-$8.24M-$9.95M-$13.51M-$10.24M-$13.83M-$15.00M-$14.31M-$13.14M
Income tax$151,000$133,000$149,000$186,000$128,000$177,000$135,000$38,000
Net income-$8.39M-$10.08M-$13.65M-$10.43M-$13.96M-$15.17M-$14.45M-$13.18M
EBITDA-$7.29M-$8.86M-$12.76M-$9.60M-$14.09M-$14.50M-$14.26M-$13.32M
EPS (basic)-0.19-0.24-0.33—-0.34-0.38-0.36—
EPS (diluted)-0.19-0.24-0.33—-0.34-0.38-0.36—
Weighted avg. shares (diluted)43.18M42.47M41.90M—40.94M40.43M39.95M—
Balance sheet
Cash & equivalents$52.69M$55.84M$61.57M$69.75M$76.55M$75.47M$74.56M$71.16M
Receivables$12.01M$12.25M$10.83M$12.07M$13.80M$15.90M$13.97M$13.12M
Inventory$15.44M$16.39M$16.31M$15.85M$16.25M$16.18M$16.81M$16.91M
Current assets$84.06M$88.13M$92.75M$101.68M$111.23M$120.02M$123.94M$136.25M
PP&E, net$1.76M$1.89M$2.06M$2.22M$2.44M$2.66M$2.83M$2.91M
Goodwill$2.33M$2.33M$2.33M$2.33M$2.33M$2.33M$2.33M$2.33M
Intangibles———————$0
Total assets$110.21M$114.73M$119.97M$129.29M$138.28M$147.19M$150.74M$162.85M
Current liabilities$20.74M$20.41M$18.91M$20.06M$22.88M$22.45M$24.95M$24.44M
Short-term debt$100,000$103,000$104,000$106,000$105,000$104,000$7.80M$3.18M
Long-term debt$37.71M$37.43M$37.21M$36.99M$37.02M$37.01M$29.39M$34.00M
Total debt$37.81M$37.53M$37.31M$37.09M$37.13M$37.12M$37.20M$37.18M
Total liabilities$76.01M$75.54M$74.20M$75.17M$78.25M$78.10M$73.07M$77.04M
Shareholders' equity$34.20M$39.20M$45.76M$54.12M$60.03M$69.09M$77.67M$85.81M
Net debt-$14.88M-$18.31M-$24.26M-$32.66M-$39.42M-$38.35M-$37.36M-$33.98M
Shares outstanding43.55M42.95M42.24M41.67M41.25M40.74M40.25M39.79M
Cash flow statement
Operating cash flow-$3.18M-$5.21M-$10.10M-$7.08M-$8.16M-$3.91M-$13.22M-$6.73M
Capital expenditure$8,000$1,000$9,000$13,000$89,000$49,000$301,000$111,000
Free cash flow-$3.19M-$5.21M-$10.11M-$7.10M-$8.25M-$3.96M-$13.52M-$6.84M
Investing cash flow-$8,000-$1,000-$9,000-$13,000$8.71M$5.47M$16.31M$14.07M
Financing cash flow$161,000-$513,000$2.03M$55,000$181,000-$67,000$664,000$62,000
Depreciation & amortization$200,000$200,000$200,000$300,000$300,000$300,000$300,000$100,000
Stock-based compensation$3.61M$3.70M$4.14M$4.24M$5.17M$6.21M$5.61M$5.52M

Free plan shows the latest 8 periods; Pro shows all 31 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.